The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 21807512 |
29 |
Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL. |
University of Washington |
| 20405848 |
48 |
Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors. |
Chinese Academy of Sciences |
| 18603434 |
15 |
The discovery of small molecule chemical probes of Bcl-X(L) and Mcl-1. |
Entremed |
| 29453135 |
99 |
Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A. |
Universit£ |
| 29407973 |
35 |
Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents. |
Hunan Provinc |
| 27749061 |
26 |
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules. |
University of Maryland |
| 10227113 |
22 |
Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro. |
Eli Lilly |
| 20609415 |
6 |
Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. |
Kyowa Hakko Kogyo |
Search and Browse
